These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 22247358

  • 1. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Núñez-Alvarez CA, Llorente L, Sánchez-Guerrero J.
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [Abstract] [Full Text] [Related]

  • 2. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Nuñez-Alvarez CA, Llorente L.
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [Abstract] [Full Text] [Related]

  • 3. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.
    PLoS One; 2008 Oct 06; 3(10):e3347. PubMed ID: 18836530
    [Abstract] [Full Text] [Related]

  • 4. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun 06; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
    Arthritis Rheum; 2007 Apr 06; 56(4):1242-50. PubMed ID: 17393453
    [Abstract] [Full Text] [Related]

  • 6. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A, Bengtsson AA, Nived O, Ryberg B, Truedsson L, Rönnblom L, Alm GV, Sturfelt G.
    Lupus; 2003 Apr 06; 12(11):846-50. PubMed ID: 14667101
    [Abstract] [Full Text] [Related]

  • 7. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan 06; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
    Lu XY, Ye S, Wang Y, Guo L, Chen XX, Fan W, Wang XD, Gu YY, Bao CD, Liu Q.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2462-6. PubMed ID: 17156673
    [Abstract] [Full Text] [Related]

  • 9. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Sep 19; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 10. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 19; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 11. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul 19; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 12. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y, Nakamura J.
    World J Biol Psychiatry; 2010 Mar 19; 11(2):121-8. PubMed ID: 20109107
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
    Hopia L, Thangarajh M, Khademi M, Laveskog A, Wallström E, Svenungsson E, Andersson M.
    Scand J Rheumatol; 2011 Mar 19; 40(5):363-72. PubMed ID: 21585290
    [Abstract] [Full Text] [Related]

  • 14. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST.
    Arthritis Rheum; 2004 Mar 19; 50(3):858-65. PubMed ID: 15022328
    [Abstract] [Full Text] [Related]

  • 15. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y, Yanagida T, Hirohata S.
    Arthritis Rheum; 2008 Apr 19; 58(4):1130-5. PubMed ID: 18383393
    [Abstract] [Full Text] [Related]

  • 16. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A.
    Lupus; 2015 Dec 19; 24(14):1492-7. PubMed ID: 26124236
    [Abstract] [Full Text] [Related]

  • 17. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T, Okamoto H, Kurasawa K, Dei Y, Hirohata S, Minota S.
    Lupus; 2016 Aug 19; 25(9):997-1003. PubMed ID: 26846690
    [Abstract] [Full Text] [Related]

  • 18. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
    Sibbitt WL, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM.
    J Rheumatol; 2002 Jul 19; 29(7):1536-42. PubMed ID: 12136916
    [Abstract] [Full Text] [Related]

  • 19. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
    Iikuni N, Okamoto H, Yoshio T, Sato E, Kamitsuji S, Iwamoto T, Momohara S, Taniguchi A, Yamanaka H, Minota S, Kamatani N.
    Ann Rheum Dis; 2006 Feb 19; 65(2):253-6. PubMed ID: 16410530
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
    Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T, Nishimura K, Kamatani N, Hara M.
    J Rheumatol; 2007 Oct 19; 34(10):2010-7. PubMed ID: 17896804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.